The Paediatric EVICEL® Neuro Study

NCT02309645 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
40
Enrollment
INDUSTRY
Sponsor class

Stopped Study completed the required elements (40 paediatric subjects) per regulatory requirement. The study enrolled 40/42 subjects. No safety signals were identified. No changes required to the statistical analysis as described in the protocol.

Conditions

Interventions

Sponsor

Ethicon, Inc.